Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis
Bacterial vaginosis (BV) is typically caused by a shift in the vaginal microbiota from a Lactobacillus-dominant community to one colonised by strains of Gardenerella vaginalis and treatment with the antibiotic metronidazole (MNZ) often results in failure and recurrence. Here, the authors use modelli...
Guardado en:
Autores principales: | Christina Y. Lee, Ryan K. Cheu, Melissa M. Lemke, Andrew T. Gustin, Michael T. France, Benjamin Hampel, Andrea R. Thurman, Gustavo F. Doncel, Jacques Ravel, Nichole R. Klatt, Kelly B. Arnold |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d83bafea6184047b1ac4bc5543da3b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
por: Zhi-Luo Deng, et al.
Publicado: (2018) -
Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
por: Catriona S Bradshaw, et al.
Publicado: (2012) -
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
por: Cindy M. Liu, et al.
Publicado: (2015) -
Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression.
por: Nina Zemanová, et al.
Publicado: (2021) -
Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression
por: Nina Zemanová, et al.
Publicado: (2021)